Belzutifan Versus Everolimus in Participants (pts) with Previously Treated Advanced Renal Cell Carcinoma (RCC): Patient-reported Outcomes (pros) in the Phase 3 LITESPARK-005 Study.
JOURNAL OF CLINICAL ONCOLOGY(2024)
Key words
Intratumor Heterogeneity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined